» Articles » PMID: 30626209

Multicenter Study of the Validity of Additional Freeze Cycles for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: The AD-Balloon Study

Abstract

Background: Pulmonary vein isolation (PVI) is a cornerstone of catheter ablation in patients with paroxysmal atrial fibrillation, and balloon-based ablation has been recently performed worldwide. The second-generation cryoballoon (CB2) ablation has proven to be highly effective in achieving freedom from paroxysmal atrial fibrillation. However, there are some debatable questions, including the ideal number of freeze cycles.

Methods: The AD-Balloon study (Multicenter Study of the Validity of Additional Freeze Cycles for Cryoballoon Ablation) was designed as a prospective, multicenter, and randomized clinical trial for investigation of the optimal strategy of freeze cycles for the CB2 ablation. One hundred and ten consecutive patients (aged 64±11 years) were randomly assigned to 2 groups after achieving a PVI by the CB2 ablation: 3-minute freeze cycles were added to each pulmonary vein (AD group: n=55) or not (non-AD group: n=55). Delayed-enhancement magnetic resonance imaging was also performed 1 to 2 months after the PVI to assess the ablation lesions.

Results: The patient characteristics did not differ between the 2 groups. A complete PVI was achieved in all patients. The total number of freeze cycles and durations for all pulmonary veins were significantly shorter in the non-AD group than in the AD group (5.7±1.6 versus 9.1±1.6 cycles, P<0.0001, and 932±244 versus 1483±252 seconds, P<0.0001). The cumulative freedom from any atrial tachyarrhythmia at 1 year was 87.3% in the AD group and 89.1% in the non-AD group (log-rank test P=0.78). There was no significant difference in the frequency of gaps on the PVI lines in the delayed-enhancement magnetic resonance imaging (46% in the AD group versus 36% in the non-AD group; P=0.38).

Conclusions: No benefit was found in the patients receiving additional 3-minute freeze cycles after the complete PVI with the CB2 ablation, suggesting that an insurance freeze after achieving a PVI with the CB2 may be unnecessary and time consuming.

Citing Articles

Single-shot technique of cryoablation for atrial fibrillation has comparable effective and safety outcomes compared to standard technique: insights from multiple clinical studies.

He C, Zhang W, Yin L, Sun M, Zhao Z, Ye G Front Cardiovasc Med. 2023; 10:1195492.

PMID: 37745124 PMC: 10512731. DOI: 10.3389/fcvm.2023.1195492.


Real-world comparison of in-hospital complications after catheter ablation for atrial fibrillation between non-antivitamin K anticoagulants and warfarin: A propensity-matched analysis using nation-wide database.

Miyamoto K, Murata S, Takegami M, Nakajima K, Kamakura T, Wada M Int J Cardiol Heart Vasc. 2023; 44:101174.

PMID: 36687335 PMC: 9852281. DOI: 10.1016/j.ijcha.2023.101174.


A multicenter prospective randomized study comparing the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation between cryoballoon and radiofrequency ablation (Embo-Abl study): Study design.

Miyamoto K, Kanaoka K, Ohta Y, Yoh M, Takahashi H, Tonegawa-Kuji R Clin Cardiol. 2022; 46(2):214-222.

PMID: 36413635 PMC: 9933100. DOI: 10.1002/clc.23949.


Cryoballoon Ablation versus Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation (CRRF-PeAF): Protocol for a Prospective, Multicenter, Randomized, Controlled Study.

Miyamoto K, Kanaoka K, Yoh M, Takahashi H, Kishihara J, Ishikura M Int J Cardiol Heart Vasc. 2022; 41:101074.

PMID: 35782707 PMC: 9241129. DOI: 10.1016/j.ijcha.2022.101074.


Primary results of the Spanish Cryoballoon Ablation Registry: acute and long-term outcomes of the RECABA study.

Ferrero-de-Loma-Osorio A, Cozar R, Garcia-Alberola A, Valles E, Barrera A, Toquero J Sci Rep. 2021; 11(1):17268.

PMID: 34446764 PMC: 8390492. DOI: 10.1038/s41598-021-96655-3.